Jinan Tonglu assisted Sinopharm to obtain production approval for omeprazole enteric-coated tablets
On February 22, 2022, the State Drug Administration issued an announcement that the omeprazole enteric-coated tablets (specification: 20mg) developed by Jinan Tonglu Pharmaceutical with the assistance of Sinopharm Industry passed the consistency evaluation of generic drugs, and it is the third domestic company to pass the Omeprazole Consistency Evaluation. A company that evaluates the quality and efficacy of generic meprazole enteric-coated tablets.
The product process of omeprazole enteric-coated tablets is that the plain tablets are enteric-coated, and the production cost is much lower than that of enteric-coated capsules, which greatly enhances the competitiveness of production enterprises to participate in centralized procurement.
XCH Biomedical Stability Test Chamber provides excellent stability testing performance for manufacturers of pharmaceuticals, cosmetics, food and personal care products, in compliance with the International Conference on Harmonization (ICH) guidelines on bulk drug and product storage testing.
Comprehensive medicine stability test chamber